Results 341 to 350 of about 499,883 (421)

Patients' and gastroenterologists' preferences regarding outcomes and medication attributes in ulcerative colitis. [PDF]

Ann Gastroenterol
Katsoula A, Giouleme O, Paschos P, Toumpalidou M, Mainou M, Malandris K, Haidich AB, Tsapas A.   +7 more
europepmc   +1 more source

How “Sure” Are We About Precision Medicine in IBD?

United European Gastroenterology Journal, EarlyView.
Florian Tran, Konrad Aden
wiley   +1 more source

Systematic Multi‐Trait Study of Genetic Correlation and Causality Relationships Between General Medical Conditions and Mental Disorders

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Increasing evidence has highlighted bidirectional associations between mental disorders and general medical conditions, with underlying causes ranging from lifestyle habits and side effects from medications to genetic contributions. Novel methods now provide a way to estimate the shared genetic underpinnings and the possibility of
Ron Nudel, Maria Da Re, Michael E. Benros   +2 more
wiley   +1 more source

Endoplasmic reticulum stress in gut inflammation: Implications for ulcerative colitis and Crohn's disease. [PDF]

World J Gastroenterol
Zheng T, Huang KY, Tang XD, Wang FY, Lv L.   +4 more
europepmc   +1 more source

ULCERATIVE COLITIS

Annals of Surgery, 1928
openaire   +3 more sources

CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome. [PDF]

Sci Rep
Shibao T, Hase H, Mizokami K, Usui A, Kitae K, Ueda Y, Jingushi K, Tsujikawa K.   +7 more
europepmc   +1 more source

Using Biologics to Reduce Long‐Term Corticosteroid Use in Pyoderma Gangrenosum: Real‐World Evidence From Two Centres

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a challenging inflammatory skin disorder. While corticosteroids offer a rapid response, their long‐term risks necessitate alternative treatments. Objective To compare the long‐term effectiveness of biologic therapies versus systemic corticosteroids in PG management. Methods A retrospective analysis of 15
R. Cascio Ingurgio, A. Alfano, L. Gargiulo, L. Ibba, A. Narcisi, F. Satgé, M. Stark, A. Costanzo, D. F. Murrell   +8 more
wiley   +1 more source

Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study. [PDF]

Open Life Sci
He T, Song LQ, Weng XY, Pan P, Ding H, Liu MQ, Qiu SL, Sun SM.   +7 more
europepmc   +1 more source

The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs

Allergy, EarlyView.
We uncover an unprecedented role for IgE in CD. CD patients, regardless of allergic status and similar to allergic patients, display higher levels of circulating IgE+ and FcεRI+ immune cells, including pDCs, which are concomitant to fewer Tregs. In vitro experiments show that the anti‐IgE monoclonal antibody omalizumab restores the ability of pDCs from
Andrés de la Rocha‐Muñoz, Cristina Benito‐Villalvilla, David Olivares, Sofía Sirvent, Miguel A. García‐Brenes, Alba Angelina, Leticia Martín‐Cruz, Javier Cuesta, Paolo Tassinari, Xavier Jaumont, Carlos Taxonera, Oscar Palomares   +11 more
wiley   +1 more source